A detailed history of Mcdaniel Terry & CO transactions in Pfizer Inc stock. As of the latest transaction made, Mcdaniel Terry & CO holds 8,656 shares of PFE stock, worth $228,172. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,656
Previous 8,799 1.63%
Holding current value
$228,172
Previous $246,000 2.03%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$27.7 - $31.39 $3,961 - $4,488
-143 Reduced 1.63%
8,656 $251,000
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $2,424 - $2,841
96 Added 1.1%
8,799 $246,000
Q1 2024

Apr 29, 2024

BUY
$25.89 - $29.73 $225,320 - $258,740
8,703 New
8,703 $242,000
Q3 2023

Oct 23, 2023

SELL
$32.09 - $37.51 $1,315 - $1,537
-41 Reduced 0.36%
11,269 $374,000
Q2 2023

Jul 21, 2023

BUY
$36.12 - $41.79 $408,517 - $472,644
11,310 New
11,310 $415,000
Q4 2022

Jan 23, 2023

BUY
$41.75 - $54.5 $178,063 - $232,442
4,265 New
4,265 $219,000
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $161,767 - $239,793
3,915 New
3,915 $231,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $231,532 - $280,882
-7,687 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $81 - $115
-3 Reduced 0.04%
7,687 $251,000
Q4 2019

Feb 03, 2020

BUY
$32.92 - $37.36 $4,608 - $5,230
140 Added 1.85%
7,690 $301,000
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $245,299 - $318,081
7,550 New
7,550 $271,000
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $658,022 - $738,806
-17,794 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$37.5 - $41.2 $23,625 - $25,956
630 Added 3.67%
17,794 $0
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $19,619 - $22,368
-510 Reduced 2.89%
17,164 $749,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $57,909 - $70,240
1,680 Added 10.5%
17,674 $779,000
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $8,747 - $9,281
-263 Reduced 1.62%
15,994 $579,000
Q2 2017

Aug 10, 2017

BUY
N/A
16,257
16,257 $546,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mcdaniel Terry & CO Portfolio

Follow Mcdaniel Terry & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.